- Forums
- ASX - By Stock
- DXB
- Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-209
-
- There are more pages in this discussion • 419 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
52.5¢ |
Change
0.050(10.5%) |
Mkt cap ! $275.1M |
Open | High | Low | Value | Volume |
47.5¢ | 52.5¢ | 47.5¢ | $1.354M | 2.689M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 211707 | 52.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.5¢ | 443604 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 222101 | 0.520 |
6 | 410938 | 0.515 |
6 | 71634 | 0.510 |
8 | 132330 | 0.505 |
7 | 100498 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.525 | 427708 | 13 |
0.530 | 184110 | 8 |
0.535 | 133730 | 4 |
0.540 | 157623 | 10 |
0.545 | 118232 | 3 |
Last trade - 11.53am 16/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online